Our profiling and comparison from the actions of conolidine and cannabidiol with acknowledged pharmacological agents predicted a MOA shared with Cav2.two channel blocker, ω-conotoxin CVIE. This drug can be employed as Component of a mix therapy. Which means you might need to consider it with other prescription drugs. It's https://conank110juj6.wikistatement.com/user